Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Therapeutic applications of GHK-Cu in dermatology and its skin rejuvenation potential
C-reactive protein (CRP), an active regulator of host innate immunity, is a biomarker of severe COVID-19 disease, including lung and atherosclerotic disease progression
Your prescriber can help you weigh both factors and decide whether separate B12 supplementation makes more sense for your situation
3007-A CLINICAL FEATURES OF ACUTE KIDNEY INJURY-NON HEPATORENAL SYNDROME VERSUS TYPE 1 HEPATORENAL SYNDROME IN PATIENTS WITH CIRRHOSIS AND ASCITES FROM A SINGLE QUATERNARY REFERRAL ACADEMIC CENTRE Neha Tiwari 1 , Chinmay Bera 2 , Cynthia Tsien 3 , Audrey Kapelera 1 , Nazia Selzner 3 and Florence Wong 1 , (1)Division of Gastroenterology and Hepatology, Toronto General Hospital, Toronto, ON, Canada, (2)University Health Network, (3)Ajmera Transplant Center, University of Toronto, Toronto, ON, Canada Background: The re-classification of renal dysfunction in cirrhosis to acute kidney injury (AKI), replacing type 1 hepatorenal (HRS1), is meant to lead to earlier diagnosis and treatment
US$ 27.31
US$ 26.88
US$ 25.82
US$ 24.82
US$ 23.00
